Lentiviral vector-mediated gene transfer and uses thereof
CA 2432301 C · Owner: Appukuttan, Binoy · Inventors: Appukuttan, Binoy; Stout, J. Timothy
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a means of human gene therapy for inherited or acquired proliferative ocular disease. It furnishes methods to exploit the ability of lentiviral vectors to transduce both mitotically active and inactive cells so that eye diseases may be treated.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 18, 2001 and granted June 4, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 18, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 18, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.